查看购物车
  • Traditional Chinese
  • English
  • Japanese
2021-2031年亚太地区基因检测服务市场报告（范围、细分、动态和竞争分析）
市场调查报告书
商品编码
1819711

2021-2031年亚太地区基因检测服务市场报告（范围、细分、动态和竞争分析）

Asia Pacific Genetic Testing Services Market Report 2021-2031 by Scope, Segmentation, Dynamics, and Competitive Analysis
出版日期: | 出版商: The Insight Partners | 英文 192 Pages | 订单完成后即时交付

价格

亚太地区基因检测服务市场预计将大幅成长，到 2031 年将达到 25.501 亿美元，高于 2023 年的 7.2838 亿美元。这一成长代表着 2023 年至 2031 年的年复合成长率(CAGR) 为 17.0%。

执行摘要和市场分析

亚太地区 (APAC) 的基因检测服务市场正在快速扩张，这得益于医疗保健投资的增加、技术进步以及人们对遗传疾病认识的提高等诸多因素。中国、印度、日本和韩国等主要国家对基因检测的需求显着增长，尤其是在癌症诊断、产前筛检和罕见遗传疾病的鑑定等领域。个人化医疗的发展以及基因组研究的进步，进一步推动了市场的发展。此外，旨在改善医疗基础设施和促进基因研究的政府措施预计将促进市场的持续发展。主要行业参与者的加入也促进了该地区的创新，并提高了服务的可及性。

市场区隔分析

基因检测服务市场可以根据服务类型、疾病和服务提供者进行细分。

1. 服务类型：市场分为几类，包括预测检测、带因者检测、产前检测、新生儿筛检、诊断性基因检测等。 2023年，预测性检测领域占据了最大的市场份额。

2. 疾病：市场也依疾病类型细分，包括癌症、心血管疾病、代谢疾病和其他疾病。癌症领域是2023年市场的最大贡献者。

3. 服务提供者：市场按服务提供者类型分类，包括医院实验室、诊断实验室和其他提供者。 2023年，医院实验室占据了最大的市场。

市场展望

全球遗传疾病的发生率不断上升，令人担忧，因为这些疾病会严重影响健康。遗传疾病通常症状罕见，且往往无法治癒。许多此类疾病非常罕见，源自于个体基因突变。根据世界卫生组织 (WHO) 2021 年的数据，每 1,000 人中约有 10 人患有单基因疾病，这意味着全球有 7,000 万至 8,000 万人患有此类疾病。全球基因组织已发现约 7000 种罕见疾病和病症，且新的疾病仍在持续发现中。

谢菲尔德大学的研究估计，全球约有3亿人患有遗传疾病。 MJH生命科学公司2022年的报告强调，每年约有30万名新生儿被诊断​​出患有镰状细胞疾病，约占全球人口的5%。

在亚太和中东地区，大量个体被诊断出患有遗传疾病，部分原因是许多社区近亲结婚盛行。此类婚姻导致遗传疾病发生率上升，从而增加了对基因检测服务的需求，进而推动了市场成长。

国家洞察

亚太地区基因检测服务市场主要包括中国、日本、印度、澳洲、韩国等国。中国在2023年占据了最大的市场。

近年来，中国公众对基因检测益处的认识显着提高。直接面向消费者 (DTC) 的检测方式提高了便利性和可近性，对市场成长产生了正面影响。中国科学家和权威机构强调了遗传物质在疾病研究和治疗、药物开发以及先天性残疾方面的潜力。

根据2020年7月发表的一项题为《聚焦中国基因治疗》的研究，中国有超过5700万人患有遗传疾病，每年报告约400万例新发癌症病例。全球癌症观察站报告称，2020年中国共有4568754例癌症病例。此外，2023年2月发表的一篇文章指出，中国约有2,000万人患有罕见疾病。

中国从独生子女政策转向全面二胎政策，预计增加出生人口，进而增加新生儿基因检测的需求。此外，中科院于2016年启动的「精准医疗计画」旨在到2030年对超过1亿个人类基因组进行定序，预算为92亿美元。 2021年7月，中国基因公司华大基因集团与军方合作开发了产前检测，收集了数百万名女性的基因资料，用于对唐氏症等性状和异常进行广泛研究。预计这些因素将显着推动中国基因检测服务市场的成长。

公司简介

亚太地区基因检测服务市场的主要参与者包括 Eurofins Scientific SE、Exact Sciences Corp、Laboratory Corp of America Holdings、23andMe Holding Co、Ambry Genetics Corp、Quest Diagnostics Inc、Illumina Inc、F. Hoffmann-La Roche Ltd、NeoGenomics Inc、Centogene NV Genetics, Inc、VERITAS INTERCONTINENTAL 和 GeneDx, LLC 等。这些公司正在采用扩张、产品创新和併购等各种策略来增强其产品服务并提高市场份额。

目录

第一章：简介

第 2 章：执行摘要

  • 关键见解

第三章：研究方法

  • 二次研究
  • 初步研究
    • 假设表述：
    • 宏观经济因素分析：
    • 显影基数：
    • 数据三角测量：
    • 国家级资料：

第四章：亚太地区基因检测服务市场－主要市场动态

  • 市场驱动因素
    • 遗传疾病盛行率上升
    • 提高对个人化医疗的认识和接受度
    • 直接面向消费者（DTC）基因检测的偏好日益增长
  • 市场限制
    • 基因检测的社会和伦理影响
    • 基因服务的可负担性
  • 市场机会
    • 发展中国家尚未开发的新兴市场
  • 未来趋势
    • 人工智慧基因检测
  • 影响分析：

第五章：基因检测服务市场－亚太地区分析

  • 2021-2031年亚太地区基因检测服务市场收入
  • 亚太地区基因检测服务市场预测分析

第六章：亚太地区基因检测服务市场分析－依服务类型

  • 预测测试
  • 携带者检测
  • 产前检查
  • 新生儿筛检
  • 诊断性基因检测
  • 其他的

第七章：亚太地区基因检测服务市场分析－依疾病

  • 癌症
  • 心血管疾病
  • 代谢性疾病
  • 其他疾病

第八章：亚太地区基因检测服务市场分析－服务提供者

  • 医院实验室
  • 诊断实验室
  • 其他服务提供者

第九章：亚太地区基因检测服务市场—国家分析

  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
    • 亚太地区其他地区

第 10 章：基因检测服务市场-产业格局

  • 概述
  • 基因检测服务市场的成长策略
  • 有机成长策略
    • 概述
  • 无机成长策略
    • 概述

第 11 章：公司简介

  • Eurofins Scientific SE
  • Exact Sciences Corp
  • Laboratory Corp of America Holdings
  • andMe Holding Co
  • Ambry Genetics Corp
  • Quest Diagnostics Inc
  • Illumina Inc
  • F. Hoffmann-La Roche Ltd
  • NeoGenomics Inc
  • Centogene NV
  • Ancestry Genomics Inc
  • Gene By Gene Ltd
  • SIVOTEC BioInformatics LLC
  • Progenesis
  • Fulgent Genetics, Inc
  • VERITAS INTERCONTINENTAL
  • GeneDx, LLC

第 12 章：附录

Product Code: BMIRE00030242

The Asia Pacific genetic testing services market is projected to grow significantly, reaching an estimated US$ 2,550.10 million by 2031, up from US$ 728.38 million in 2023. This growth represents a compound annual growth rate (CAGR) of 17.0% from 2023 to 2031.

Executive Summary and Market Analysis

The genetic testing services market in the Asia Pacific (APAC) region is experiencing rapid expansion, driven by several factors including increased healthcare investments, advancements in technology, and heightened awareness of genetic disorders. Key countries such as China, India, Japan, and South Korea are witnessing a notable rise in demand for genetic testing, particularly in areas such as cancer diagnosis, prenatal screening, and the identification of rare genetic diseases. The growth of personalized medicine, alongside advancements in genomic research, is further propelling the market forward. Additionally, government initiatives aimed at improving healthcare infrastructure and promoting genetic research are expected to bolster ongoing market development. The presence of major industry players is also fostering innovation and enhancing accessibility within the region.

Market Segmentation Analysis

The genetic testing services market can be segmented based on service type, disease, and service provider.

1. Service Type: The market is divided into several categories, including predictive testing, carrier testing, prenatal testing, newborn screening, diagnostic genetic testing, and others. In 2023, the predictive testing segment held the largest market share.

2. Disease: The market is also segmented by disease type, including cancer, cardiovascular diseases, metabolic diseases, and other conditions. The cancer segment was the largest contributor to the market in 2023.

3. Service Provider: The market is categorized by service provider type, which includes hospital-based laboratories, diagnostic laboratories, and other providers. Hospital-based laboratories accounted for the largest share of the market in 2023.

Market Outlook

The increasing prevalence of genetic diseases globally is a significant concern, as these conditions can severely impact health. Genetic diseases often present with uncommon symptoms and are frequently non-curable. Many of these diseases are rare and arise from mutations in individuals' genetic makeup. According to the World Health Organization (WHO) in 2021, approximately 10 out of every 1,000 individuals are affected by single-gene diseases, indicating that between 70 million and 80 million people worldwide are living with such conditions. The Global Genes organization has identified around 7,000 rare diseases and disorders, with new ones being discovered regularly.

Research from the University of Sheffield estimates that around 300 million people globally are affected by genetic diseases. A report from MJH Life Sciences in 2022 highlighted that approximately 300,000 newborns are diagnosed with sickle cell disease each year, representing about 5% of the global population.

In the Asia Pacific and Middle East regions, a significant number of individuals are diagnosed with genetic diseases, partly due to the prevalence of consanguineous marriages in many communities. Such marriages contribute to the rising incidence of genetic disorders, thereby increasing the demand for genetic testing services, which in turn drives market growth.

Country Insights

The Asia Pacific genetic testing services market includes several key countries: China, Japan, India, Australia, South Korea, and others. China held the largest market share in 2023.

In recent years, awareness of the benefits of genetic testing has significantly increased in China. The availability of direct-to-consumer (DTC) tests has improved convenience and accessibility, positively influencing market growth. Chinese scientists and authorities have emphasized the potential of genetic material in studying and treating diseases, developing pharmaceuticals, and understanding congenital disabilities.

According to a study titled "Spotlight on Gene Therapy in China," published in July 2020, over 57 million individuals in China suffer from genetic diseases, with approximately 4 million new cancer cases reported annually. The Global Cancer Observatory reported a total of 4,568,754 cancer cases in China in 2020. Furthermore, an article published in February 2023 noted that around 20 million people in China are affected by rare diseases.

The shift from a one-child policy to a universal two-child policy in China is expected to increase the number of births, thereby enhancing the demand for newborn genetic testing. Additionally, the Precision Medicine Initiative, launched by the Chinese Academy of Sciences in 2016, aims to sequence over 100 million human genomes by 2030, with a budget of US$ 9.2 billion. In July 2021, BGI Group, a Chinese gene company, developed a prenatal test in collaboration with the military, which collects genetic data from millions of women for extensive research on traits and abnormalities such as Down syndrome. These factors are anticipated to significantly drive the growth of the genetic testing services market in China.

Company Profiles

Key players in the Asia Pacific genetic testing services market include Eurofins Scientific SE, Exact Sciences Corp, Laboratory Corp of America Holdings, 23andMe Holding Co, Ambry Genetics Corp, Quest Diagnostics Inc, Illumina Inc, F. Hoffmann-La Roche Ltd, NeoGenomics Inc, Centogene NV, Ancestry Genomics Inc, Gene By Gene Ltd, SIVOTEC BioInformatics LLC, Progenesis, Fulgent Genetics, Inc, VERITAS INTERCONTINENTAL, and GeneDx, LLC, among others. These companies are employing various strategies such as expansion, product innovation, and mergers and acquisitions to enhance their offerings and increase market share.

Table Of Contents

1. Introduction

  • 1.1 Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macroeconomic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country-level data:

4. Asia Pacific Genetic Testing Services Market - Key Market Dynamics

  • 4.1 Market Drivers
    • 4.1.1 Rising Prevalence of Genetic Diseases
    • 4.1.2 Increasing Awareness and Acceptance of Personalized Medicines
    • 4.1.3 Growing Preference for Direct-To-Consumer (DTC) Genetic Testing
  • 4.2 Market Restraints
    • 4.2.1 Social and Ethical Implications of Genetic Testing
    • 4.2.2 Affordability of Genetic Services
  • 4.3 Market Opportunities
    • 4.3.1 Untapped Emerging Markets in Developing Countries
  • 4.4 Future Trends
    • 4.4.1 Artificial Intelligence-Powered Genetic Testing
  • 4.5 Impact Analysis:

5. Genetic Testing Services Market - Asia Pacific Analysis

  • 5.1 Asia Pacific Genetic Testing Services Market Revenue (US$ Million), 2021-2031
  • 5.2 Asia Pacific Genetic Testing Services Market Forecast Analysis

6. Asia Pacific Genetic Testing Services Market Analysis - by Service Type

  • 6.1 Predictive Testing
    • 6.1.1 Overview
    • 6.1.2 Predictive Testing: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 6.2 Carrier Testing
    • 6.2.1 Overview
    • 6.2.2 Carrier Testing: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 6.3 Prenatal Testing
    • 6.3.1 Overview
    • 6.3.2 Prenatal Testing: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 6.4 New-born Screening
    • 6.4.1 Overview
    • 6.4.2 New-born Screening: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 6.5 Diagnostic Genetic Testing
    • 6.5.1 Overview
    • 6.5.2 Diagnostic Genetic Testing: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 6.6 Others
    • 6.6.1 Overview
    • 6.6.2 Others: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

7. Asia Pacific Genetic Testing Services Market Analysis - by Disease

  • 7.1 Cancer
    • 7.1.1 Overview
    • 7.1.2 Cancer: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.2 Cardiovascular Diseases
    • 7.2.1 Overview
    • 7.2.2 Cardiovascular Diseases: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.3 Metabolic Diseases
    • 7.3.1 Overview
    • 7.3.2 Metabolic Diseases: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.4 Other Diseases
    • 7.4.1 Overview
    • 7.4.2 Other Diseases: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

8. Asia Pacific Genetic Testing Services Market Analysis - by Service Providers

  • 8.1 Hospital-Based Laboratories
    • 8.1.1 Overview
    • 8.1.2 Hospital-Based Laboratories: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 8.2 Diagnostic Laboratories
    • 8.2.1 Overview
    • 8.2.2 Diagnostic Laboratories: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 8.3 Other Service Providers
    • 8.3.1 Overview
    • 8.3.2 Other Service Providers: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

9. Asia Pacific Genetic Testing Services Market - Country Analysis

  • 9.1 Asia Pacific
    • 9.1.1 Asia Pacific Genetic Testing Services Market - Revenue and Forecast Analysis - by Country
      • 9.1.1.1 Asia Pacific Genetic Testing Services Market - Revenue and Forecast Analysis - by Country
      • 9.1.1.2 China: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 9.1.1.2.1 China: Asia Pacific Genetic Testing Services Market Share - by Service Type
        • 9.1.1.2.2 China: Asia Pacific Genetic Testing Services Market Share - by Disease
        • 9.1.1.2.3 China: Asia Pacific Genetic Testing Services Market Share - by Cancer Disease
        • 9.1.1.2.4 China: Asia Pacific Genetic Testing Services Market Share - by Service Providers
      • 9.1.1.3 Japan: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 9.1.1.3.1 Japan: Asia Pacific Genetic Testing Services Market Share - by Service Type
        • 9.1.1.3.2 Japan: Asia Pacific Genetic Testing Services Market Share - by Disease
        • 9.1.1.3.3 Japan: Asia Pacific Genetic Testing Services Market Share - by Cancer Disease
        • 9.1.1.3.4 Japan: Asia Pacific Genetic Testing Services Market Share - by Service Providers
      • 9.1.1.4 India: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 9.1.1.4.1 India: Asia Pacific Genetic Testing Services Market Share - by Service Type
        • 9.1.1.4.2 India: Asia Pacific Genetic Testing Services Market Share - by Disease
        • 9.1.1.4.3 India: Asia Pacific Genetic Testing Services Market Share - by Cancer Disease
        • 9.1.1.4.4 India: Asia Pacific Genetic Testing Services Market Share - by Service Providers
      • 9.1.1.5 Australia: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 9.1.1.5.1 Australia: Asia Pacific Genetic Testing Services Market Share - by Service Type
        • 9.1.1.5.2 Australia: Asia Pacific Genetic Testing Services Market Share - by Disease
        • 9.1.1.5.3 Australia: Asia Pacific Genetic Testing Services Market Share - by Cancer Disease
        • 9.1.1.5.4 Australia: Asia Pacific Genetic Testing Services Market Share - by Service Providers
      • 9.1.1.6 South Korea: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 9.1.1.6.1 South Korea: Asia Pacific Genetic Testing Services Market Share - by Service Type
        • 9.1.1.6.2 South Korea: Asia Pacific Genetic Testing Services Market Share - by Disease
        • 9.1.1.6.3 South Korea: Asia Pacific Genetic Testing Services Market Share - by Cancer Disease
        • 9.1.1.6.4 South Korea: Asia Pacific Genetic Testing Services Market Share - by Service Providers
      • 9.1.1.7 Rest of APAC: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 9.1.1.7.1 Rest of APAC: Asia Pacific Genetic Testing Services Market Share - by Service Type
        • 9.1.1.7.2 Rest of APAC: Asia Pacific Genetic Testing Services Market Share - by Disease
        • 9.1.1.7.3 Rest of APAC: Asia Pacific Genetic Testing Services Market Share - by Cancer Disease
        • 9.1.1.7.4 Rest of APAC: Asia Pacific Genetic Testing Services Market Share - by Service Providers

10. Genetic Testing Services Market - Industry Landscape

  • 10.1 Overview
  • 10.2 Growth Strategies in Genetic Testing Services Market
  • 10.3 Organic Growth Strategies
    • 10.3.1 Overview
  • 10.4 Inorganic Growth Strategies
    • 10.4.1 Overview

11. Company Profiles

  • 11.1 Eurofins Scientific SE
    • 11.1.1 Key Facts
    • 11.1.2 Business Description
    • 11.1.3 Products and Services
    • 11.1.4 Financial Overview
    • 11.1.5 SWOT Analysis
    • 11.1.6 Key Developments
  • 11.2 Exact Sciences Corp
    • 11.2.1 Key Facts
    • 11.2.2 Business Description
    • 11.2.3 Products and Services
    • 11.2.4 Financial Overview
    • 11.2.5 SWOT Analysis
    • 11.2.6 Key Developments
  • 11.3 Laboratory Corp of America Holdings
    • 11.3.1 Key Facts
    • 11.3.2 Business Description
    • 11.3.3 Products and Services
    • 11.3.4 Financial Overview
    • 11.3.5 SWOT Analysis
    • 11.3.6 Key Developments
  • 11.4andMe Holding Co
    • 11.4.1 Key Facts
    • 11.4.2 Business Description
    • 11.4.3 Products and Services
    • 11.4.4 Financial Overview
    • 11.4.5 SWOT Analysis
    • 11.4.6 Key Developments
  • 11.5 Ambry Genetics Corp
    • 11.5.1 Key Facts
    • 11.5.2 Business Description
    • 11.5.3 Products and Services
    • 11.5.4 Financial Overview
    • 11.5.5 SWOT Analysis
    • 11.5.6 Key Developments
  • 11.6 Quest Diagnostics Inc
    • 11.6.1 Key Facts
    • 11.6.2 Business Description
    • 11.6.3 Products and Services
    • 11.6.4 Financial Overview
    • 11.6.5 SWOT Analysis
    • 11.6.6 Key Developments
  • 11.7 Illumina Inc
    • 11.7.1 Key Facts
    • 11.7.2 Business Description
    • 11.7.3 Products and Services
    • 11.7.4 Financial Overview
    • 11.7.5 SWOT Analysis
    • 11.7.6 Key Developments
  • 11.8 F. Hoffmann-La Roche Ltd
    • 11.8.1 Key Facts
    • 11.8.2 Business Description
    • 11.8.3 Products and Services
    • 11.8.4 Financial Overview
    • 11.8.5 SWOT Analysis
    • 11.8.6 Key Developments
  • 11.9 NeoGenomics Inc
    • 11.9.1 Key Facts
    • 11.9.2 Business Description
    • 11.9.3 Products and Services
    • 11.9.4 Financial Overview
    • 11.9.5 SWOT Analysis
    • 11.9.6 Key Developments
  • 11.10 Centogene NV
    • 11.10.1 Key Facts
    • 11.10.2 Business Description
    • 11.10.3 Products and Services
    • 11.10.4 Financial Overview
    • 11.10.5 SWOT Analysis
    • 11.10.6 Key Developments
  • 11.11 Ancestry Genomics Inc
    • 11.11.1 Key Facts
    • 11.11.2 Business Description
    • 11.11.3 Products and Services
    • 11.11.4 Financial Overview
    • 11.11.5 SWOT Analysis
    • 11.11.6 Key Developments
  • 11.12 Gene By Gene Ltd
    • 11.12.1 Key Facts
    • 11.12.2 Business Description
    • 11.12.3 Products and Services
    • 11.12.4 Financial Overview
    • 11.12.5 SWOT Analysis
    • 11.12.6 Key Developments
  • 11.13 SIVOTEC BioInformatics LLC
    • 11.13.1 Key Facts
    • 11.13.2 Business Description
    • 11.13.3 Products and Services
    • 11.13.4 Financial Overview
    • 11.13.5 SWOT Analysis
    • 11.13.6 Key Developments
  • 11.14 Progenesis
    • 11.14.1 Key Facts
    • 11.14.2 Business Description
    • 11.14.3 Products and Services
    • 11.14.4 Financial Overview
    • 11.14.5 SWOT Analysis
    • 11.14.6 Key Developments
  • 11.15 Fulgent Genetics, Inc
    • 11.15.1 Key Facts
    • 11.15.2 Business Description
    • 11.15.3 Products and Services
    • 11.15.4 Financial Overview
    • 11.15.5 SWOT Analysis
    • 11.15.6 Key Developments
  • 11.16 VERITAS INTERCONTINENTAL
    • 11.16.1 Business Description
    • 11.16.2 Products and Services
    • 11.16.3 Financial Overview
    • 11.16.4 SWOT Analysis
    • 11.16.5 Key Developments
  • 11.17 GeneDx, LLC
    • 11.17.1 Key Facts
    • 11.17.2 Business Description
    • 11.17.3 Products and Services
    • 11.17.4 Financial Overview
    • 11.17.5 SWOT Analysis
    • 11.17.6 Key Developments

12. Appendix

  • 12.1 About The Insight Partners
  • 12.2 Glossary of Terms

List Of Tables

  • Table 1. Asia Pacific Genetic Testing Services Market Segmentation
  • Table 2. Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Table 3. Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Service Type
  • Table 4. Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Disease
  • Table 5. Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Service Providers
  • Table 6. Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Country
  • Table 7. China: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Service Type
  • Table 8. China: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Disease
  • Table 9. China: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Cancer Disease
  • Table 10. China: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Service Providers
  • Table 11. Japan: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Service Type
  • Table 12. Japan: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Disease
  • Table 13. Japan: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Cancer Disease
  • Table 14. Japan: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Service Providers
  • Table 15. India: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Service Type
  • Table 16. India: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Disease
  • Table 17. India: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Cancer Disease
  • Table 18. India: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Service Providers
  • Table 19. Australia: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Service Type
  • Table 20. Australia: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Disease
  • Table 21. Australia: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Cancer Disease
  • Table 22. Australia: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Service Providers
  • Table 23. South Korea: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Service Type
  • Table 24. South Korea: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Disease
  • Table 25. South Korea: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Cancer Disease
  • Table 26. South Korea: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Service Providers
  • Table 27. Rest of APAC: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Service Type
  • Table 28. Rest of APAC: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Disease
  • Table 29. Rest of APAC: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Cancer Disease
  • Table 30. Rest of APAC: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Service Providers
  • Table 31. Recent Organic Growth Strategies in Genetic Testing Services Market
  • Table 32. Recent Inorganic Growth Strategies in the Genetic Testing Services Market
  • Table 33. Glossary of Terms, Genetic Testing Services Market

List Of Figures

  • Figure 1. Asia Pacific Genetic Testing Services Market Segmentation - Country
  • Figure 2. Asia Pacific Genetic Testing Services Market - Key Market Dynamics
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Asia Pacific Genetic Testing Services Market Revenue (US$ Million), 2021-2031
  • Figure 5. Asia Pacific Genetic Testing Services Market Share (%) - by Service Type (2023 and 2031)
  • Figure 6. Predictive Testing: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 7. Carrier Testing: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 8. Prenatal Testing: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 9. New-born Screening: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 10. Diagnostic Genetic Testing: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 11. Others: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 12. Asia Pacific Genetic Testing Services Market Share (%) - by Disease (2023 and 2031)
  • Figure 13. Cancer: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 14. Cardiovascular Diseases: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 15. Metabolic Diseases: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 16. Other Diseases: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 17. Asia Pacific Genetic Testing Services Market Share (%) - by Service Providers (2023 and 2031)
  • Figure 18. Hospital-Based Laboratories: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 19. Diagnostic Laboratories: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 20. Other Service Providers: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 21. Asia Pacific Genetic Testing Services Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 22. China: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 23. Japan: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 24. India: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 25. Australia: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 26. South Korea: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 27. Rest of APAC: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 28. Growth Strategies in Genetic Testing Services Market